Precigen (PGEN) Non-Current Deferred Tax Liability (2015 - 2024)

Precigen's (PGEN) quarterly Non-Current Deferred Tax Liability came in at $1.3 million in Q4 2024, down 88.39% year-on-year from $10.9 million in Q1 2024, and up 1328.09% on a QoQ basis from $89000.0 in Q3 2024.

Precigen (PGEN) Non-Current Deferred Tax Liability (2015 - 2024) Analysis & Trends

Precigen (PGEN) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $1.3 million in Q4 2024.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 88.39% year-over-year to $1.3 million in Q4 2024; TTM through Dec 2024 was $1.3 million, a 88.39% decrease from a year earlier, with the FY2024 full-year figure at $1.3 million, down 88.39% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2024 stood at $1.3 million, up from $89000.0 in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for PGEN reached as high as $18.5 million in Q4 2021 and fell as low as $77000.0 in Q2 2024.
  • Historically, Non-Current Deferred Tax Liability has averaged $3.9 million across 5 years, with a median of $2.4 million in 2022.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 383.69% in 2023 and slumped 96.47% in 2024, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $12.6 million in 2020, then soared by 47.0% to $18.5 million in 2021, then sank by 87.8% to $2.3 million in 2022, then jumped by 383.69% to $10.9 million in 2023, then plunged by 88.39% to $1.3 million in 2024.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $1.3 million in Q4 2024, $89000.0 in Q3 2024, and $77000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 1.27 Mn
Dec 31, 2024 1.27 Mn
Sep 30, 2024 89,000.00
Sep 30, 2024 89,000.00
Jun 30, 2024 77,000.00
Jun 30, 2024 77,000.00
Mar 31, 2024 1.78 Mn
Mar 31, 2024 1.78 Mn
Dec 31, 2023 10.95 Mn
Dec 31, 2023 10.95 Mn
Sep 30, 2023 2.13 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 2.18 Mn
Jun 30, 2023 2.18 Mn
Mar 31, 2023 2.24 Mn
Mar 31, 2023 2.24 Mn
Dec 31, 2022 2.26 Mn
Dec 31, 2022 2.26 Mn
Sep 30, 2022 2.09 Mn
Sep 30, 2022 2.09 Mn